Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams SA, Walker BD, Pasternack MS, Luster AD.

Nature. 1998 Feb 26;391(6670):908-11.

PMID:
9495345
3.

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.

Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15341-5.

4.

Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.

Price DA, Sewell AK, Dong T, Tan R, Goulder PJ, Rowland-Jones SL, Phillips RE.

Curr Biol. 1998 Mar 12;8(6):355-8.

5.

Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.

Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S.

Blood. 2000 Feb 15;95(4):1167-74.

6.

RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation.

Appay V, Dunbar PR, Cerundolo V, McMichael A, Czaplewski L, Rowland-Jones S.

Int Immunol. 2000 Aug;12(8):1173-82.

PMID:
10917892
7.

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P.

Science. 1995 Dec 15;270(5243):1811-5.

PMID:
8525373
8.

IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.

Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.

J Leukoc Biol. 2002 Oct;72(4):735-42.

PMID:
12377943
9.

Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.

Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.

J Leukoc Biol. 2000 Sep;68(3):405-12.

PMID:
10985258
12.
13.

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.

Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, Wigzell H.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15382-7.

14.
15.
16.

Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection.

Nilsson J, Kinloch-de-Loes S, Granath A, Sönnerborg A, Goh LE, Andersson J.

AIDS. 2007 Mar 12;21(5):565-74.

PMID:
17314518
18.

Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants.

Czaplewski LG, McKeating J, Craven CJ, Higgins LD, Appay V, Brown A, Dudgeon T, Howard LA, Meyers T, Owen J, Palan SR, Tan P, Wilson G, Woods NR, Heyworth CM, Lord BI, Brotherton D, Christison R, Craig S, Cribbes S, Edwards RM, Evans SJ, Gilbert R, Morgan P, Randle E, Schofield N, Varley PG, Fisher J, Waltho JP, Hunter MG.

J Biol Chem. 1999 Jun 4;274(23):16077-84.

19.

Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH.

Masson D, Peters PJ, Geuze HJ, Borst J, Tschopp J.

Biochemistry. 1990 Dec 25;29(51):11229-35.

PMID:
2125503
20.

Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA.

Zou W, Foussat A, Capitant C, Durand-Gasselin I, Bouchet L, Galanaud P, Levy Y, Emilie D.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):31-8.

PMID:
10534144

Supplemental Content

Support Center